Table 3 Detected pathogens among patients with clinical signs of respiratory tract infection or bloodstream infection

Community-acquired pneumonia and bacteraemia, n (%)

1 (0.6)

0

1 (2.4)

 Streptococcus pneumoniae^a (day 1)

1 (0.6)

0

1 (2.4)

Hospital-acquired pneumonia, n (%)

1 (0.6)

1 (0.8)

0

 Haemophilus influenzae (day 6)

1 (0.6)

1 (0.8)

0

Ventilator-associated pneumonia (among 34 patients), n (%)

-

-

5 (14.7)

 Acinetobacter baumannii MDR/ Aspergillus fumigatus (day 20)

-

-

1 (2.9)

 Escherichia coli^b (day 7)

-

-

1 (2.9)

 Enterobacter cloacae group^c (day 10)

-

-

1 (2.9)

 Aspergillus fumigatus (day 13)

-

-

1 (2.9)

 Culture negative (day 10)

-

-

1 (2.9)

Hospital-acquired tracheobronchitis, n (%)

13 (8.0)

0

13 (39.0)

 Staphylococcus aureus^d (day 3)

1 (0.6)

0

1 (2.4)

 Staphylococcus aureus^d/Klebsiella aerogenes^e (day 15)

1 (0.6)

0

1 (2.4)

 Escherichia coli (day 17)

1 (0.6)

0

1 (2.4)

 Klebsiella aerogenes (day 12)

1 (0.6))

0

1 (2.4)

 Klebsiella pneumoniae/Proteus mirabilis (day 18)

1 (0.6)

0

1 (2.4)

 Klebsiella variicola (day 20)

1 (0.6)

0

2 (4.9)

 Serratia marcescens ^c (day 5 and day 25)

1 (0.6)

0

2 (4.9)

 Pseudomonas aeruginosa (day 4 and day 13)

2 (1.2)

0

2 (4.9)

 Stenotrophomonas maltophilia^e (day 24)

1 (0.6)

0

1 (2.4)

 Culture negative (day 4)

1 (0.6)

0

1 (2.4)

Hospital-acquired bloodstream infection, n (%)

5 (3.1)

0

4 (9.8)

 Staphylococcus epidermidis (day 44)

1 (0.6)

0

1 (2.4)

 Escherichia coli^b (day 16)

1 (0.6)

0

1 (2.4)

 Citrobacter koseri (day 4)

1 (0.6)

1 (0.8)

0

 Pseudomonas aeruginosa (day 8)

1 (0.6)

0

1 (2.4)

 Candida albicans (day 14)

1 (0.6)

0

1 (2.4)